Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Debt / NOTE 1.500%10/1
-
Number of holders
-
41
-
Total principal
-
308M
-
Principal change
-
+228K
-
Total reported value, excl. options
-
$331M
-
Value change
-
+$243K
-
Number of buys
-
2
-
Price
-
$1.07
Significant Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q4 2013
41 filings reported holding 09061GAF8 - BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q4 2013.
BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 has 41 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $308M of principal
.
Largest 10 bondholders include AVIVA PLC ($50.7M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($46.8M of principal), OAKTREE CAPITAL MANAGEMENT LP ($37.5M of principal), CALAMOS ADVISORS LLC ($34.7M of principal), BlackRock Advisors LLC ($13.6M of principal), FRANKLIN RESOURCES INC ($12.5M of principal), Polar Securities Inc. ($10M of principal), JPMORGAN CHASE & CO ($10M of principal), Invesco Ltd. ($8.28M of principal), and ROYAL BANK OF CANADA ($8.27M of principal).
This table shows the top 41 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.